-
Brincidofovir, sold
under the
brand name Tembexa, is an
antiviral drug used to
treat smallpox.
Brincidofovir is a
prodrug of cidofovir.
Conjugated to a...
- its
effectiveness for
smallpox biothreat preparedness. In June 2021,
brincidofovir was
approved for
medical use in the
United States for the treatment...
-
basis in the
event of a
bioterror incident involving smallpox cases.
Brincidofovir, a
cidofovir derivative with much
higher activity against smallpox that...
- low-resource setting, and
helped to
organise the
trial for the drug
brincidofovir during the 2014
Ebola virus outbreak. Lang
started her
career working...
-
significant risks from
tecovirimat and low
certainty evidence that
suggests brincidofovir may
cause mild
liver injury. Pain is
common and may be severe; supportive...
- the
hospital contacted Chimerix, a
biotechnology company developing Brincidofovir to
combat the disease. The next day, Duncan's
organs were failing, and...
- but no proven,
effective therapy is
known in humans. For example,
Brincidofovir (1-O-hexadecyloxypropyl-cidofovir /CMX001)
available as Tembexa, suppresses...
-
Forest ebolavirus TAFV
Zaire ebolavirus EBOV Drug
candidates BCX4430
Brincidofovir DZNep Favipiravir FGI-103 FGI-104 FGI-106 JK-05
Lamivudine mAb114 TKM-Ebola...
-
Forest ebolavirus TAFV
Zaire ebolavirus EBOV Drug
candidates BCX4430
Brincidofovir DZNep Favipiravir FGI-103 FGI-104 FGI-106 JK-05
Lamivudine mAb114 TKM-Ebola...
-
determine its
safety and
effectiveness in humans.
Another example is
brincidofovir. In June 2021, the FDA
approved this drug for the
treatment of smallpox...
